Socially Adept: Pharma Companies Must Proactively Gauge Risk Tolerance For Online Promotions, Experts Advise

Absent formal FDA guidance, pharmaceutical manufacturers must decide how much risk they are willing to take with Internet and social media product promotion and be capable of walking away from certain online venues, panelists say at the FDLI annual meeting.